Your session is about to expire
← Back to Search
Behavioural Intervention
iPACES for Parkinson's Disease (iPACES-PD Trial)
N/A
Waitlist Available
Led By Cay Anderson-Hanley, PhD
Research Sponsored by iPACES LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 3 months
Awards & highlights
iPACES-PD Trial Summary
This trial will test if an exercise system can improve cognitive ability for people with mild cognitive impairment or Parkinson's Disease. Participants will exercise at home 3-5 times/wk for 6+ mos, then be evaluated. Remote participation, own/supplied equipment, & measures.
Who is the study for?
This trial is for people over 50 with mild cognitive impairment or Parkinson's Disease who can commit to a year-long study, exercise 3-5 times weekly for at least 6 months using an under-table elliptical, and are comfortable with English. They need approval from their doctor to exercise and must be able to use touch screens despite any tremors.Check my eligibility
What is being tested?
The study tests the iPACES system, a neuro-exergaming setup designed for home use that combines physical and cognitive exercises. Participants will engage in these activities remotely using either personal devices or equipment provided by the study.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include typical exercise-related risks such as muscle strain or fatigue. The remote nature of the trial suggests minimal risk but participants should monitor for any discomfort related to technology use.
iPACES-PD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
everyday function
executive function
Secondary outcome measures
PD-ADLs
biomarker
visuospatial function
iPACES-PD Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: iPACES (interactive Physical and Cognitive Exercise System)Experimental Treatment1 Intervention
iPACES (interactive Physical and Cognitive Exercise System) involves a "pedal-to-play" neuro-exergame in which physical and mental exercise are combined in an interactive way. In this condition a person will pedal to control forward motion in a tablet-based game, such as when pedaling along a virtual path and steering to different assigned errand locations.
Group II: PACE (physical and cognitive exercise)Active Control1 Intervention
PACE (Physical and Cognitive Exercise) involves a "pedal-while-play" experience in which physical and mental exercise are combined in a simultaneous, but not fully interactive way. In this condition a person will pedal while also separately steering in a tablet-based game, such as when pedaling while automatically progressing along a virtual path to different assigned errand locations.
Find a Location
Who is running the clinical trial?
Adirondack Neuropsychological AssociatesUNKNOWN
1 Previous Clinical Trials
120 Total Patients Enrolled
Albany Medical CollegeOTHER
91 Previous Clinical Trials
11,377 Total Patients Enrolled
Center for Balance, Mobility & Wellness at Gordon CollegeUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a significant history of heart problems.I have a significant history of stroke.I have a significant history of neurological conditions like seizures.I am 50 years old or older.I can participate in the study for one year, including completing surveys and attending video calls.I can use an under-table elliptical machine.
Research Study Groups:
This trial has the following groups:- Group 1: iPACES (interactive Physical and Cognitive Exercise System)
- Group 2: PACE (physical and cognitive exercise)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there open slots at this moment for participants in the trial?
"According to information hosted on clinicaltrials.gov, this study is not currently enrolling participants. The trial was posted originally on August 1st of 2023 and last updated April 11th of the same year; however, there are 1068 other trials actively recruiting at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger